» Articles » PMID: 25893384

Astrocytosis Precedes Amyloid Plaque Deposition in Alzheimer APPswe Transgenic Mouse Brain: a Correlative Positron Emission Tomography and in Vitro Imaging Study

Overview
Date 2015 Apr 21
PMID 25893384
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Pathological studies suggest that neuroinflammation is exacerbated by increased beta-amyloid (Aβ) levels in the brain early in Alzheimer's disease (AD). The time course and relationships between astrocytosis and Aβ deposition were examined using multitracer in vivo positron emission tomography (PET) imaging in an AD transgenic mouse model, followed by postmortem autoradiography and immunohistochemistry analysis.

Methods: PET imaging with the amyloid plaque tracer (11)C-AZD2184 and the astroglial tracer (11)C-deuterium-L-deprenyl ((11)C-DED) was carried out in APPswe mice aged 6, 8-15 and 18-24 months (4-6 animals/group) and in wild-type (wt) mice aged 8-15 and 18-24 months (3-6 animals/group). Tracer uptake was quantified by region of interest analysis using PMOD software and a 3-D digital mouse brain atlas. Postmortem brain tissues from the same APPswe and wt mice in all age groups were analysed for Aβ deposition and astrocytosis by in vitro autoradiography using (3)H-AZD2184, (3)H-Pittsburgh compound B (PIB) and (3)H-L-deprenyl and immunostaining performed with antibodies for Aβ42 and glial fibrillary acidic protein (GFAP) in sagittal brain sections.

Results: (11)C-AZD2184 PET retention in the cerebral cortices of APPswe mice was significantly higher at 18-24 months than in age-matched wt mice. Cortical and hippocampal (11)C-DED PET binding was significantly higher at 6 months than at 8-15 months or 18-24 months in APPswe mice, and it was also higher than at 8-15 months in wt mice. In vitro autoradiography (3)H-AZD2184 and (3)H-PIB binding confirmed the in vivo findings with (11)C-AZD2184 and demonstrated age-dependent increases in Aβ deposition in APPswe cortex and hippocampus. There were no significant differences between APPswe and wt mice in (3)H-L-deprenyl autoradiography binding across age groups. Immunohistochemical quantification demonstrated more Aβ42 deposits in the cortex and hippocampus and more GFAP(+) reactive astrocytes in the hippocampus at 18-24 months than at 6 months in APPswe mice.

Conclusion: The findings provide further in vivo evidence that astrocytosis occurs early in AD, preceding Aβ plaque deposition.

Citing Articles

Mapping reactive astrogliosis in Parkinson's brain with astroglial tracers BU99008 and Deprenyl: New insights from a multi-marker postmortem study.

Rocha F, Roy A, Varshney M, Kumar A Alzheimers Dement. 2025; 21(2):e14488.

PMID: 39936538 PMC: 11848164. DOI: 10.1002/alz.14488.


Glial fibrillary acidic protein in Alzheimer's disease: a narrative review.

Leipp F, Vialaret J, Mohaupt P, Coppens S, Jaffuel A, Niehoff A Brain Commun. 2024; 6(6):fcae396.

PMID: 39554381 PMC: 11568389. DOI: 10.1093/braincomms/fcae396.


Cerebrovascular disease is associated with Alzheimer's plasma biomarker concentrations in adults with Down syndrome.

Edwards N, Lao P, Alshikho M, Ericsson O, Rizvi B, Petersen M Brain Commun. 2024; 6(5):fcae331.

PMID: 39403075 PMC: 11472828. DOI: 10.1093/braincomms/fcae331.


Research progress on humoral biomarkers of Alzheimer's disease: A review.

Zhang H, Fu X, Yang M, Song X, Li M, Wang X Medicine (Baltimore). 2024; 103(30):e38978.

PMID: 39058878 PMC: 11272379. DOI: 10.1097/MD.0000000000038978.


PET imaging of neuroinflammation: any credible alternatives to TSPO yet?.

Chauveau F, Winkeler A, Chalon S, Boutin H, Becker G Mol Psychiatry. 2024; 30(1):213-228.

PMID: 38997465 DOI: 10.1038/s41380-024-02656-9.


References
1.
Nelissen N, Van Laere K, Thurfjell L, Owenius R, Vandenbulcke M, Koole M . Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease. J Nucl Med. 2009; 50(8):1251-9. DOI: 10.2967/jnumed.109.063305. View

2.
Kawarabayashi T, Younkin L, Saido T, Shoji M, Ashe K, Younkin S . Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci. 2001; 21(2):372-81. PMC: 6763819. View

3.
Gulyas B, Pavlova E, Kasa P, Gulya K, Bakota L, Varszegi S . Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography. Neurochem Int. 2010; 58(1):60-8. DOI: 10.1016/j.neuint.2010.10.013. View

4.
Andersson J, Varnas K, Cselenyi Z, Gulyas B, Wensbo D, Finnema S . Radiosynthesis of the candidate beta-amyloid radioligand [(11)C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys. Synapse. 2010; 64(10):733-41. DOI: 10.1002/syn.20782. View

5.
Olabarria M, Noristani H, Verkhratsky A, Rodriguez J . Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia. 2010; 58(7):831-8. DOI: 10.1002/glia.20967. View